Areas of Research
- Head and Neck Cancer
The Cata Laboratory is dedicated to deciphering the role of mu-opioid receptor signaling in head and neck squamous cell carcinoma. In 2014, Cata founded the Anesthesiology and Surgical Oncology Research Group. His group is focused on translational and clinical research and is dedicated to investigating the impact of perioperative interventions on oncological outcomes. He has several funded clinical trials and has published more than 220 peer-reviewed publications.